Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Optometry
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Power List / 2017 / Honorees / David Sung Yong Kang

David Sung Yong Kang

  • Profile

About David Sung Yong Kang

David Sung Yong Kang

Founder and Clinical Director at Eyereum Ophthalmic Clinic and CEO of Eyereum Healthcare, the Republic of Korea


Kang also serves as outpatient Clinical Associate Professor at Ulsan University, Asan Medical Center and as out-patient Assistant Clinical Professor at Severance Hospital, Yonsei University School of Medicine in Seoul. His primary passion is corneal wavefront-guided ablation for amelioration of aberrations for keratoconus, cornea ectasia, and central islands. Kang has received three Best Academic Achievement Awards from the Korean Ophthalmological Society, including the Best Video Award. To date, he has rights to six patents. His first patent, registered in 2008, involves using circumlinear capsulorhexis technology during cataract surgery. Since then he has patented new methods of de-epithelization of the cornea prior to refractive surface ablation, removing phakic IOLs, and removing lenticules during SMILE.


Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: